Document is current
Any future updates will be listed below
-
Authors
El-Kassas, Mohamed https://orcid.org/0000-0002-3396-6894
Younossi, Zobair M.
- License Information
-
More Information
Article History
First Online: 8 January 2026
Competing interests
: M.E.-K. reports having served as an investigator, speaker and/or advisory board member for AstraZeneca, Roche, MSD, AbbVie, Eva, Multicare, Mash Premier, Takeda, Organon, AUG, Inspire, HSO, Gilead, Janssen, Intercept, Rameda, FPI, Ipsen, Onxeo, Sanofi, Sandoz, Al Andalus Pharma, Minapharm, Pharco, Zeta, Alfa Cure, Bayer, Oncoustics, PDC, Acino, Opella, Spimaco and Novo Nordisk. Z.M.Y. has received research funding and/or serves as consultant to Intercept, Cymabay, Boehringer Ingelheim, Ipsen, BMS, GSK, NovoNordisk, Siemens, Madridgal, Merck and Abbott.
